Investor Relations

Our mission is to revolutionize healthcare by defining, diagnosing, and restoring the functional health of the gut microbiome to prevent and treat chronic diseases, thereby improving health span and longevity.

Latest Investor Update

Downloads coming soon

Press Releases

Our Solutions

First in class evidence-based solutions to treat and prevent human disease by diagnosing and treating dysbiosis.

Generating data to develop microbiome-based interventions.